Loading company…
Signature Therapeutics develops biopharmaceutical therapies.
Founded in 2003, Signature Therapeutics focused on developing biopharmaceutical therapies and was based in Palo Alto, US. It raised USD 10.00 mn in a round led by Founders Fund. In December 2015, it merged with Ensysce Biosciences Inc., backed by the Texas Emerging Technology Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in